Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Bioventus (BVS) Depreciation & Amortization (IS) (2020 - 2025)

Bioventus (BVS) has disclosed Depreciation & Amortization (IS) for 5 consecutive years, with $1.8 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Depreciation & Amortization (IS) fell 17.57% year-over-year to $1.8 million, compared with a TTM value of $8.9 million through Mar 2024, down 11.3%, and an annual FY2024 reading of $7.7 million, down 13.46% over the prior year.
  • Depreciation & Amortization (IS) was $1.8 million for Q1 2024 at Bioventus, down from $2.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $3.3 million in Q2 2022 and bottomed at $1.8 million in Q1 2024.
  • Average Depreciation & Amortization (IS) over 5 years is $2.3 million, with a median of $2.1 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (IS) skyrocketed 69.04% in 2022, then tumbled 34.57% in 2023.
  • Year by year, Depreciation & Amortization (IS) stood at $1.8 million in 2020, then rose by 6.18% to $1.9 million in 2021, then skyrocketed by 40.05% to $2.7 million in 2022, then dropped by 14.91% to $2.3 million in 2023, then decreased by 23.5% to $1.8 million in 2024.
  • Business Quant data shows Depreciation & Amortization (IS) for BVS at $1.8 million in Q1 2024, $2.3 million in Q3 2023, and $2.1 million in Q2 2023.